1. Home
  2. CNTX vs PNF Comparison

CNTX vs PNF Comparison

Compare CNTX & PNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • PNF
  • Stock Information
  • Founded
  • CNTX 2015
  • PNF 2001
  • Country
  • CNTX United States
  • PNF United States
  • Employees
  • CNTX N/A
  • PNF N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • PNF Finance Companies
  • Sector
  • CNTX Health Care
  • PNF Finance
  • Exchange
  • CNTX Nasdaq
  • PNF Nasdaq
  • Market Cap
  • CNTX 60.7M
  • PNF 53.5M
  • IPO Year
  • CNTX 2021
  • PNF N/A
  • Fundamental
  • Price
  • CNTX $0.84
  • PNF $7.00
  • Analyst Decision
  • CNTX Strong Buy
  • PNF
  • Analyst Count
  • CNTX 5
  • PNF 0
  • Target Price
  • CNTX $6.50
  • PNF N/A
  • AVG Volume (30 Days)
  • CNTX 257.9K
  • PNF 29.1K
  • Earning Date
  • CNTX 05-07-2025
  • PNF 01-01-0001
  • Dividend Yield
  • CNTX N/A
  • PNF 5.17%
  • EPS Growth
  • CNTX N/A
  • PNF N/A
  • EPS
  • CNTX N/A
  • PNF N/A
  • Revenue
  • CNTX N/A
  • PNF N/A
  • Revenue This Year
  • CNTX N/A
  • PNF N/A
  • Revenue Next Year
  • CNTX N/A
  • PNF N/A
  • P/E Ratio
  • CNTX N/A
  • PNF N/A
  • Revenue Growth
  • CNTX N/A
  • PNF N/A
  • 52 Week Low
  • CNTX $0.55
  • PNF $6.37
  • 52 Week High
  • CNTX $2.75
  • PNF $9.06
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 56.99
  • PNF 35.72
  • Support Level
  • CNTX $0.80
  • PNF $6.65
  • Resistance Level
  • CNTX $0.89
  • PNF $7.63
  • Average True Range (ATR)
  • CNTX 0.11
  • PNF 0.16
  • MACD
  • CNTX 0.03
  • PNF -0.03
  • Stochastic Oscillator
  • CNTX 73.80
  • PNF 35.71

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About PNF PIMCO New York Municipal Income Fund

PIMCO New York Municipal Income Fund is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund's portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.

Share on Social Networks: